DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $909,038 | +3.4% | 3,664 | 0.0% | 0.30% | +34.7% |
Q2 2023 | $879,360 | -7.1% | 3,664 | -2.4% | 0.22% | -9.8% |
Q1 2023 | $946,662 | -5.0% | 3,756 | 0.0% | 0.25% | -3.9% |
Q4 2022 | $996,918 | -2.5% | 3,756 | -5.1% | 0.26% | -16.1% |
Q3 2022 | $1,022,000 | +1.9% | 3,956 | 0.0% | 0.30% | +6.6% |
Q2 2022 | $1,003,000 | -13.5% | 3,956 | 0.0% | 0.29% | -1.4% |
Q1 2022 | $1,160,000 | +11.9% | 3,956 | +25.5% | 0.29% | +15.5% |
Q4 2021 | $1,037,000 | +8.0% | 3,153 | 0.0% | 0.25% | -2.3% |
Q3 2021 | $960,000 | +13.5% | 3,153 | 0.0% | 0.26% | +15.8% |
Q2 2021 | $846,000 | +19.2% | 3,153 | 0.0% | 0.22% | +9.4% |
Q1 2021 | $710,000 | +1.4% | 3,153 | 0.0% | 0.20% | -11.4% |
Q4 2020 | $700,000 | +3.1% | 3,153 | 0.0% | 0.23% | -13.6% |
Q3 2020 | $679,000 | +21.7% | 3,153 | 0.0% | 0.26% | +18.8% |
Q2 2020 | $558,000 | +28.0% | 3,153 | 0.0% | 0.22% | +10.4% |
Q1 2020 | $436,000 | -9.9% | 3,153 | 0.0% | 0.20% | +26.2% |
Q4 2019 | $484,000 | +6.4% | 3,153 | 0.0% | 0.16% | -4.8% |
Q3 2019 | $455,000 | +2.9% | 3,153 | 0.0% | 0.17% | +5.7% |
Q2 2019 | $442,000 | – | 3,153 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |